Thyvilayil S, Vellamgot A, Salameh K, Kurunthattilthazhe S, Elikkottil A, Dominguez L
BMC Pediatr. 2025; 25(1):41.
PMID: 39825283
PMC: 11740512.
DOI: 10.1186/s12887-025-05398-x.
Dammann A, Chamby A, Catomeris A, Davidson K, Tettelin H, van Pijkeren J
PLoS Pathog. 2021; 17(3):e1009116.
PMID: 33684178
PMC: 7971860.
DOI: 10.1371/journal.ppat.1009116.
Sun J, Fang W, Ke B, He D, Liang Y, Ning D
Sci Rep. 2016; 6:26319.
PMID: 27215811
PMC: 4877633.
DOI: 10.1038/srep26319.
Bhushan R, Anthony B, Frasch C
Infect Immun. 1998; 66(12):5848-53.
PMID: 9826364
PMC: 108740.
DOI: 10.1128/IAI.66.12.5848-5853.1998.
Klassen H, Klassen M, Huncharek M
Yale J Biol Med. 1995; 68(1-2):1-6.
PMID: 8748460
PMC: 2590844.
Lysis of erythrocytes by a hemolysin produced by a group B Streptococcus sp.
Marchlewicz B, Duncan J
Infect Immun. 1981; 34(3):787-94.
PMID: 7037641
PMC: 350940.
DOI: 10.1128/iai.34.3.787-794.1981.
Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.
Baker C, Edwards M, Webb B, Kasper D
J Clin Invest. 1982; 69(2):394-404.
PMID: 7035495
PMC: 370989.
DOI: 10.1172/jci110463.
Antagonism of ampicillin and chloramphenicol for meningeal isolates of group B streptococci.
Weeks J, Mason Jr E, Baker C
Antimicrob Agents Chemother. 1981; 20(3):281-5.
PMID: 7030197
PMC: 181688.
DOI: 10.1128/AAC.20.3.281.
Hypersusceptibility of penicillin-treated group B streptococci to bactericidal activity of human polymorphonuclear leukocytes.
Horne D, Tomasz A
Antimicrob Agents Chemother. 1981; 19(5):745-53.
PMID: 7027922
PMC: 181516.
DOI: 10.1128/AAC.19.5.745.
pH-dependent penicillin tolerance of group B streptococci.
Horne D, Tomasz A
Antimicrob Agents Chemother. 1981; 20(1):128-35.
PMID: 7025749
PMC: 181644.
DOI: 10.1128/AAC.20.1.128.
Properties of a hemolysin produced by group B streptococci.
Marchlewicz B, Duncan J
Infect Immun. 1980; 30(3):805-13.
PMID: 7014450
PMC: 551387.
DOI: 10.1128/iai.30.3.805-813.1980.
Primary carrier sites of group B streptococci in pregnant women correlated with serotype distributions and maternal parity.
Islam A
J Clin Pathol. 1981; 34(1):78-81.
PMID: 7007446
PMC: 1146416.
DOI: 10.1136/jcp.34.1.78.
Extracellular neuraminidase production by clinical isolates of group B streptococci from infected neonates.
Mattingly S, Milligan T, Pierpont A, Straus D
J Clin Microbiol. 1980; 12(4):633-5.
PMID: 6999031
PMC: 273656.
DOI: 10.1128/jcm.12.4.633-635.1980.
Micro-indirect hemagglutination test for detection of antibodies to the Ibc protein of group B Streptococcus.
Thangavelu C, Koshi G
J Clin Microbiol. 1980; 12(1):1-6.
PMID: 6999011
PMC: 273507.
DOI: 10.1128/jcm.12.1.1-6.1980.
Protective levels of human immunoglobulin G antibody to group B streptococcus type Ib.
Boyer K, Kendall L, Papierniak C, Klegerman M, GOTOFF S
Infect Immun. 1984; 45(3):618-24.
PMID: 6381309
PMC: 263339.
DOI: 10.1128/iai.45.3.618-624.1984.
Teichoic acids of Streptococcus agalactiae: chemistry, cytotoxicity, and effect on bacterial adherence to human cells in tissue culture.
Goldschmidt Jr J, Panos C
Infect Immun. 1984; 43(2):670-7.
PMID: 6363297
PMC: 264352.
DOI: 10.1128/iai.43.2.670-677.1984.
Role of adherence in the pathogenesis of neonatal group B streptococcal infection.
Broughton R, Baker C
Infect Immun. 1983; 39(2):837-43.
PMID: 6339391
PMC: 348025.
DOI: 10.1128/iai.39.2.837-843.1983.
Enhanced susceptibility of mice with streptozotocin-induced diabetes to type II group B streptococcal infection.
Edwards M, Fuselier P
Infect Immun. 1983; 39(2):580-5.
PMID: 6339383
PMC: 347991.
DOI: 10.1128/iai.39.2.580-585.1983.
Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes.
Johnson D, Ferrieri P
J Clin Microbiol. 1984; 19(4):506-10.
PMID: 6201506
PMC: 271105.
DOI: 10.1128/jcm.19.4.506-510.1984.
Unspecific binding of group B streptococcal cocytolysin (CAMP factor) to immunoglobulins and its possible role in pathogenicity.
Jurgens D, Sterzik B, Fehrenbach F
J Exp Med. 1987; 165(3):720-32.
PMID: 3546580
PMC: 2188285.
DOI: 10.1084/jem.165.3.720.